Logo
Secure Registration

International Conference on Neurology and Neurological Sciences

ICNNS

11th Nov – 12th Nov 2026 Oistins, Barbados

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

1

Select Registration Mode

2

Participant Details

3

Coupon Code

10% OFF on Registration.
Use Coupon Code → EARLY10
4

Terms & Condition

Conference Session Tracks

UN SDG Wheel

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

SDG 3 SDG 4 SDG 8 SDG 9
01 Advancements in Epilepsy Research +
This track focuses on the latest findings in epilepsy research, including novel therapeutic approaches and management strategies. It aims to bring together experts to discuss the implications of these advancements for clinical practice.
SDG 3 SDG 4
02 Innovations in Movement Disorders +
This session will explore cutting-edge research in the field of movement disorders, including Parkinson's disease and dystonia. Participants will discuss emerging treatments and the role of technology in enhancing patient care.
SDG 3 SDG 9
03 Stroke: Prevention and Rehabilitation +
This track will address the latest strategies in stroke prevention, acute management, and rehabilitation techniques. It aims to foster collaboration among researchers and clinicians to improve patient outcomes.
SDG 3 SDG 9
04 Neurocritical Care: Challenges and Solutions +
This session will delve into the complexities of neurocritical care, highlighting innovative approaches to managing critically ill neurological patients. Discussions will focus on improving protocols and outcomes in this high-stakes environment.
SDG 3 SDG 4
05 Dementia and Cognitive Disorders +
This track will examine the latest research on dementia and related cognitive disorders, including diagnostic advancements and therapeutic interventions. The goal is to enhance understanding and management of these conditions.
SDG 3 SDG 4
06 Neurorehabilitation Techniques +
This session will focus on the latest techniques and technologies in neurorehabilitation, emphasizing evidence-based practices. Participants will share insights on optimizing recovery for patients with neurological impairments.
SDG 3 SDG 4
07 Neuroimaging and Neurophysiology +
This track will explore the advancements in neuroimaging and neurophysiological techniques that enhance our understanding of neurological disorders. Discussions will include the implications of these technologies for diagnosis and treatment.
SDG 3 SDG 9
08 Neurogenetics: Insights and Implications +
This session will cover the latest discoveries in neurogenetics and their implications for understanding neurological diseases. Participants will discuss how genetic insights can inform treatment and prevention strategies.
SDG 3 SDG 4
09 Tropical Neurology: Challenges and Perspectives +
This track will address the unique challenges faced in the field of tropical neurology, including infectious diseases and their neurological manifestations. It aims to foster dialogue on improving diagnosis and treatment in resource-limited settings.
SDG 3 SDG 10
10 Neuroethics in Clinical Practice +
This session will explore the ethical considerations in neurology and neurological sciences, particularly in relation to emerging technologies and treatments. Participants will engage in discussions about the ethical implications of clinical decisions.
SDG 3 SDG 16
11 Health Economics in Neurology +
This track will examine the economic aspects of neurological care, including cost-effectiveness analyses and health outcomes. Discussions will focus on how economic considerations can influence clinical practice and policy-making.
SDG 3 SDG 8